| Literature DB >> 3681426 |
V F Da Silva1, G P Raaphorst, R Goyal, M Feeley.
Abstract
The malignant glioma cell line U-87MG was used for 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), aziridinylbenzoquinone (AZQ), cis-diaminodichloroplatinum (II) (cis-DDP), and spirohydantoin mustard (SHM) treatments at 37 degrees and 42 degrees C. With the exception of SHM, all drugs killed a greater proportion of cells at the higher temperature, as assessed by the colony-formation assay. Drug-dose enhancement ratios were 1.6, 2.8, 2, and 1:1 for BCNU, AZQ, cis-DDP, and SHM, respectively. Because methods to heat discrete volumes of brain are now available, we conclude that hyperthermic increase of BCNU, AZQ, and cis-DDP cytotoxicity might have therapeutic application for malignant gliomas.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3681426 DOI: 10.3171/jns.1987.67.6.0885
Source DB: PubMed Journal: J Neurosurg ISSN: 0022-3085 Impact factor: 5.115